SPEN is a biomarker for CDK4/6 inhibitor resistance in patients with metastatic hormone receptor positive (HR+)/HER2-breast cancerCourtney T. Van Geelen,Zhi Ling Teo,Peter Savas,Stephen J. Luen,Kylie A. Clarke,Sneha Sant,Karla J. Cowley,Franco Caramia,Kaylene J. Simpson,Fabrice Andre,Sarah-Jane Dawson,Richard Pearson,Sherene LoiCANCER RESEARCH(2023)引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要